Epicypher, Inc.
Durham, NC Doing business as Epicypher Inc.
- UEI
- UWNWSADJYYZ3
- CAGE
- 6XLY4
- Primary NAICS
- 325411 Medicinal and Botanical Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 6 Davis Dr, Durham, NC 27709, USA
- Website
- epicypher.com
- Founded
- 2012
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Genomic profiling of drug-chromatin interactions for accelerated drug development research - project summary gene… | National Center for Advancing Translational Sciences | $1,062,099 | |
| Scalable, single-molecule and single-cell chromatin accessibility profiling in primary immune cells - project summary… | National Institute of Allergy and Infectious Diseases | $999,268 | |
| Development of novel epigenetic biomarkers and detection reagents for aging - summary aging, alzheimer's disease, and… | National Institute on Aging | $3,747,976 | |
| Asymmetric nucleosome substrates to advance the study of the histone code - project summary chromatin function is… | National Institute of General Medical Sciences | $2,528,352 | |
| Versatile platform for genome-wide r-loop mapping for aging and neurodegenerative disease research - project summary… | National Institute on Aging | $3,824,548 |
About Epicypher, Inc.
Epicypher, Inc. is a biotechnology company specializing in epigenetic research tools and molecular diagnostics, with a primary focus on developing advanced technologies for studying chromatin, histone post-translational modifications (PTMs), and nucleosome-based research platforms. Located in Durham, North Carolina, the company is registered in SAM.gov as a for-profit organization and manufacturer of goods, with expertise in creating innovative scientific research tools and technologies. Through federal contract and grant awards, Epicypher provides highly specialized scientific research resources, computational platforms, and advanced molecular biology research tools to various federal agencies, with a particular emphasis on developing cutting-edge genomic mapping and detection technologies.
In terms of federal contract awards, Epicypher has demonstrated a limited contract history, with a sole identified purchase order from the National Institute of Environmental Health Sciences (NIEHS). This specific contract, valued at $33,055.75, was a firm fixed-price purchase order for the delivery of pAG-Tn5 and pAG-MNase enzymes, which are laboratory supplies used in epitranscriptomic research. The contract was awarded on a sole-source basis under Federal Acquisition Regulation (FAR) Subpart 13.106-1(b) and did not have a specific set-aside designation, supporting NIEHS's research efforts studying environmental influences on human health and disease.
Epicypher has been significantly more active in federal grant awards, receiving multiple project grants from various National Institutes of Health (NIH) agencies. These grants primarily focus on developing advanced epigenetic research technologies, including platforms for studying histone modifications, genomic mapping, and cellular research tools. Notable grant awards include projects from the National Institute on Aging, National Institute of General Medical Sciences, National Cancer Institute, and National Institute of Allergy and Infectious Diseases. The grants cover a wide range of innovative research areas such as developing tools for studying aging-associated histone modifications, creating platforms for single-cell chromatin mapping, designing molecular toolboxes for drug development, and creating ultrasensitive genomic mapping technologies. Many of these grants involve collaborative partnerships with research institutions like Baylor College of Medicine, Fred Hutchinson Cancer Research Center, and Weill Cornell Medical School, demonstrating Epicypher's commitment to advancing scientific research through technological innovation.
Quick answers
What is Epicypher, Inc.'s UEI?
Epicypher, Inc.'s Unique Entity ID (UEI) in SAM.gov is UWNWSADJYYZ3.
What is Epicypher, Inc.'s CAGE code?
Epicypher, Inc.'s CAGE code is 6XLY4.
What is Epicypher, Inc.'s primary NAICS code?
Epicypher, Inc.'s primary NAICS code is 325411 (Medicinal and Botanical Manufacturing).
Where is Epicypher, Inc. located?
Epicypher, Inc.'s physical address in SAM.gov is 6 Davis Dr, Durham, NC 27709, USA.
Is Epicypher, Inc. registered in SAM.gov?
Yes. Epicypher, Inc.'s SAM.gov registration is active through June 10, 2027.
What is Epicypher, Inc.'s most recent federal award?
Epicypher, Inc.'s most recent federal grant award is Genomic profiling of drug-chromatin interactions for accelerated drug development research - project summary gene… (R44TR006068), from National Center for Advancing Translational Sciences, on September 1, 2026.
On GovTribe
See Epicypher, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors